Brain Canada Brain Canada
FR Donate

Our directory of funded grants

383 result(s) found

Decoding the RNA stability programs that determine cell identity and function in human brain and neurodegenerative disorders

Project Overview

The brain cells in Alzheimer’s disease patients differ extensively from healthy brain cells at the molecular level: there are hundreds of genes that are normally active in the brain, but become inactive in Alzheimer’s. Similarly, Alzheimer’s disease appears to turn on hundreds of genes that ar…

See researchers on this project
Principal Investigator:
  • Hamed Najafabadi, McGill University

Defining conserved functions of RNA binding proteins in stress-granule biogenesis

Project Overview

RNA is a mobile form of genetic information that is made from our DNA and its complex regulation is extremely important to the proper functioning of our cells. Since the discovery of TDP-43 in 2006 as a substance that plays a major role in ALS, the hypothesis that abnormal regulation of RNA is criti…

See researchers on this project
Principal Investigator:
  • Eric Lecuyer, Institut de Recherches Cliniques de Montréal, Université de Montréal

Defining the mechanism of inhibition of tau aggregation by the molecular chaperone, DNAJA2

Project Overview

Alzheimer’s Disease is a progressive and fatal disease that currently afflicts up to 400,000 Canadians over the age of 65. One key observation about this disease is that there is an abnormal “clumping” (aggregation) of specific proteins such as tau. Proteins normally need to keep a certain sha…

See researchers on this project
Principal Investigator:
  • Sue-Ann Mok, University of Alberta

Detecting Behaviours of Risk in Nursing Homes using Deep Learning

Project Overview

Alzheimer’s Association International Research Grant Program: Alzheimer’s Association Research Grant (AARG) The main research question is to develop algorithms to detect behaviours of risk from videos recorded in the common area of a dementia care unit. People with dementia can have changes in j…

See researchers on this project
Principal Investigator:
  • Shehroz Khan, University Health Network

Detection and prevention of pypermutant glioma in children and young adults

Project Overview

Need for project: Replication repair deficiency (RRD) is a genetic condition that significantly increases the risk of developing cancer, particularly early in life. Gliomas are the most common brain tumour seen in children and young adults (CAYA), and occur frequently in RRD. Currently, the prevalen…

See researchers on this project
Principal Investigator:
  • Uri Tabori, The Hospital For Sick Children
Team Members:
  • Cynthia Hawkins, The Hospital For Sick Children
  • Jane Barron, Memorial University
  • Sunit Das, St. Michael's Hospital
  • Sidney E. Croul, Dalhousie University
  • Birgit Ertl-Wagner, The Hospital for Sick Children
  • Andrew Gao, University Health Network
  • Normand J Laperriere, Princess Margaret Cancer Centre
  • Julia Keith, Sunnybrook Health Sciences Centre
  • Farzad Khalvati, The Hospital for Sick Children
  • Derek Tsang, Princess Margaret Cancer Centre - UHN

Detection of misfolded TDP-43 in CSF of ALS cases: Diagnostic potential of confirmation-specific antibodies

Project Overview

A more streamlined way to diagnose ALS earlier is desperately needed as current methods can take up to two years and rely heavily on ruling out other conditions that share similar symptoms. One of the hallmarks of ALS for 97 per cent of cases is the accumulation of misfolded TDP-43 protein in motor …

See researchers on this project
Principal Investigator:
  • Yulong Sun, University Health Network (University of Toronto)

Detection of tandem repeat expansion in neurological disorders

Project Overview

In the past decade, rapid development of software has allowed detection of a wide variety of genetic risk factors in brain disorders. It has improved clinical diagnosis and gene discovery for numerous human brain disorders. However, the casual genetic risk factors identified so far generally confer …

See researchers on this project
Principal Investigator:
  • Ryan Yuen, The Hospital for Sick Children

Determination of hypothalamic neuropathology and metabolic defects in ALS

Project Overview

Amyotrophic lateral sclerosis (ALS) is a motor neuron disease leading to paralysis and death within 2-5 years from disease onset. Other hallmark features include weight loss and metabolic dysfunction. Several lines of clinical evidence indicated that higher energy expenditure (hypermetabolism) is as…

See researchers on this project
Principal Investigator:
  • Jeehye Park,

    SickKids

Team Members:
  • Hoon-Ki Sung, University of Toronto

Development and validation of reagent kits for commercial high-throughput screening of PPI s and PPI inhibitors

Project Overview

Membrane proteins, which make up approximately one-third of all proteins in a cell, are responsible for a variety of processes, making them attractive therapeutic targets for many diseases such as hypertension, diabetes, neurological disorders and cancer. Understanding membrane protein function depe…

See researchers on this project
Principal Investigator:
  • Igor Stagljar, University of Toronto

Development of a caregiver reported and weighted dementia outcome

Project Overview

Caregivers of people living with dementia know the person the best and have direct experience of how their partner’s dementia is progressing. Their experiences are pivotal in judging the real-world benefits of treatment and making decisions to keep the person at home or consider different levels o…

See researchers on this project
Principal Investigator:
  • Ayse Kuspinar, McMaster University

Development of a high throughput 3D microphysiologicalplatform for rapid automated assessment of human brain organoids response to drugs targeting neurological disorders

Project Overview

Alzheimer’s disease (AD) and Parkinson’s disease (PD) are the most common and devastating neurological diseases, with over 750,000 AD patients and over 100,000 PD patients in Canada. Drug development remains a slow, expensive and inefficient process. The biopharmaceutical industries need alterna…

See researchers on this project
Principal Investigator:
  • Thomas Durcan, Montreal Neurological Institute and Hospital, McGill University
Team Members:
  • Edward Fon, McGill University
  • Margaret Magdesian, ANANDA Devices
  • Christopher Moraes, McGill University

Development of novel oligonucleotide delivery modalities for Huntington disease

Project Overview

Huntington disease (HD) is an inherited neurodegenerative disease that affects approximately 1 in 7500 individuals in the Western world. The cause of HD is a mutation in one copy of the HTT gene, which produces the toxic mutant huntingtin protein responsible for the brain cell loss associated with t…

See researchers on this project
Principal Investigator:
  • Blair Leavitt, University of British Columbia
Team Members:
  • Danica Stanimirovic, National Research Council of Canada
  • Abedelnasser Abulrob, National Research Council of Canada
  • Jodi McBride, Oregon Health and Science University

Developmental origins of stress and self-regulation and implications for interventions to improve childhood behavior

Project Overview

Dr.  Neuenschwander’s research aims to explore how exposure to stress during pregnancy affects children’s development, specifically in relation to children whose mothers were depressed and/or on antidepressants during pregnancy. She is examining whether or not these children have problems later…

See researchers on this project
Principal Investigator:
  • Regula Neuenschwander, Child & Family Research Institute

Direct microglial reprogramming to study Parkinson’s Disease

Project Overview

The human brain is a complex organ that presents many challenges for neuroscientists. For instance, tissue availability represents a major problem given that this organ does not regenerates, making it next to impossible to obtain live tissue from patients that would allow to study how cells in the b…

See researchers on this project
Principal Investigator:
  • Janelle Drouin-Ouellet, University of Montreal

Discovery of Therapeutic Targets for FUS- and TDP43-Dependent Forms of ALS

Project Overview

The four most commonly studied ALS proteins are SOD1, TDP-43, FUS and C9ORF72. Of these, TDP-43 and FUS have the most in common. Not only do they share similar functions inside cells, but in motor neurons of people with ALS, they both accumulate in clumps outside of the area where they are supposed …

See researchers on this project
Principal Investigator:
  • Peter St. George-Hyslop, University of Toronto
Team Members:
  • Mei Zhen, Lunenfeld-Tanenbaum Research Institute, Mount Sinani Hospital
  • Peter Roy, University of Toronto
  • Ben Wolozin, Boston University
  • Clemens Kaminski, University of Cambridge

Discovery of transcriptomic biomarkers and epigenetic therapeutic targets for c9ALS and sALS

Project Overview

Dr. Belzil began her research career as a PhD student at the Université de Montréal under the guidance of world renowned geneticist and Director of the Montreal Neurological Institute and Hospital, Dr. Guy Rouleau. During this time, Dr. Belzil pursued a better understanding of the genetics behind …

See researchers on this project
Principal Investigator:
  • Veronique Belzil, Mayo Clinic

Disrupted SUMOylation facilitates rogue TDP-43 in ALS

Project Overview

Proteins are large molecules that play many essential roles in the body. They do most of the work inside cells and are necessary for the structure, function and regulation of all tissues and organs. TDP-43 is a protein that is usually found inside the cell nucleus. However, in most people with ALS, …

See researchers on this project
Principal Investigator:
  • Terry Suk, University of Ottawa

Dissecting acetylcholine/glutamate co-transmission in the striatum: importance of individual neurotransmitter in addiction and movement disorders

Project Overview

Parkinson’s disease and addiction have tremendous human and economical costs for our society. The secret to understand these pathologies lies in unravelling the functioning of a specific brain region named striatum. The striatum regulates several behavioural outputs that are affected in Parkinson…

See researchers on this project
Principal Investigator:
  • Salah El Mestikawy, Douglas Mental Health University Institute
Team Members:
  • Vania Prado, University of Western Ontario
  • Marco Prado, University of Western Ontario

Distinct neuro-immune interactions drive sex differences  in chronic pain

Project Overview

One of the most important advances in our understanding of chronic pain over the last decade or so is the realization that neurons are not the only cells in the central nervous system participating in the processing of pain signals. Immune-like “glial” cells (especially microglia and astrocytes)…

See researchers on this project
Principal Investigator:
  • Jeffrey Mogil, McGill University
Team Members:
  • Michael Salter, The Hospital for Sick Children
  • Yves De Koninck, Université Laval
  • Jason Lerch, University of Toronto

DNA methylation signatures in a rat model of Fetal Alcohol Spectrum Disorder

Project Overview

Prenatal alcohol exposure can result in abnormal brain development, causing Fetal Alcohol Spectrum Disorder (FASD), which is linked to a number of cognitive, behavioural, and immune deficits that last across the lifetime. Although the lasting effects of alcohol on development are well studied, the m…

See researchers on this project
Principal Investigator:
  • Alexandre Lussier, University of British Columbia